Cannabasa was founded in 2014 to provide high quality raw materials and APIs to the pharmaceutical industry.
In order to obtain the necessary knowledge, resources and authorizations, a multidisciplinary team with great experience in this field was built.
During the last seven years, Cannabasa has been developing this project based on the behavior of cannabis crops, market development and in collaboration with the spanish authorities.
In 2021 we were authorized by the AEMPS (Spanish Medical Agency) to produce the first batches for the validation of the manufacturing process of active pharmaceutical ingredients (API´s) for medical purposes.